Cholangiocarcinoma (CCA) is a highly malignant bile duct cancer that tends to invade and metastasize early. The epithelialmesenchymal transition (EMT) has been implicated in cancer cell invasion and metastasis, as well as in cancer cell evasion of host immunity. In this study, we investigated the interaction between atypical protein kinase C-iota (aPKC-i) and Snail in the regulation of EMT and its relationship to CCA immunosuppression. Our results demonstrated that aPKC-i, Snail, and infiltrated immunosuppressive cells were significantly up-regulated in CCA tumor tissues and linked to poor prognosis. aPKC-i induced EMT and immunosuppression by regulating Snail in vitro and in vivo, although aPKC-i did not directly interact with Snail in coimmunoprecipitation experiments. To further clarify the molecular interaction between aPKC-i and Snail in relation to EMT, quantitative iTRAQ-based phosphoproteomic analysis and liquid chromatography-tandem mass spectrometry were conducted to identify the substrates of aPKC-i-dependent phosphorylation. Combined with coimmunoprecipitation, we showed that specificity protein 1 (Sp1) was directly phosphorylated by aPKC-i on Ser59 (P-Sp1). Both Sp1 and P-Sp1 were upregulated in CCA tumor tissues and associated with clinicopathological features and poor prognosis in CCA patients. Moreover, using chromatin immunoprecipitation assays, we found that P-Sp1 regulated Snail expression by increasing Sp1 binding to the Snail promoter. P-Sp1 also regulated aPKC-i/Snail-induced EMT-like changes and immunosuppression in CCA cells. Our findings further indicated that CCA cells with EMT-like features appear to generate immunosuppressive natural T regulatory-like cluster of differentiation 4-positive (CD4 1 )CD25 -cells rather than to increase CD4 1 CD25 1 natural T regulatory cells, in part by mediating T regulatory-inducible cytokines such as transforming growth factor b1 and interleukin 2. Conclusion: These results demonstrate that aPKC-i promotes EMT and induces immunosuppression through the aPKC-i/P-Sp1/Snail signaling pathway and may be a potential therapeutic target for CCA. (HEPATOLOGY 2017;66:1165-1182).
C holangiocarcinoma (CCA) is a highly malignant and poorly differentiated bile duct cancer with limited therapeutic options. Radical surgical resection represents the most promising potential curative approach for patients.
(1) However, even with aggressive surgical treatment, the rates of postoperative recurrence in resected CCA patients are high, typically ranging between 67% and 75%. (2) Postsurgical outcomes are largely due to the propensity of CCA to invade the vasculature early and to evade immune surveillance.
In recent years, growing evidence has highlighted a critical role for the epithelial-mesenchymal transition (EMT) in promoting cancer metastasis and in immune escape, including in CCA. (3, 4) During EMT, differentiated epithelial cells lose apical-basal polarity and acquire cell motility with decreased adhesive ability, including the down-regulation of epithelial markers such as Ecadherin and the up-regulation of mesenchymal markers such as N-cadherin. (5) EMT is regulated by various transcription factors such as Snail, Slug, Twist1/2, and ZEB1/2. Snail is an important transcription factor that regulates EMT by repressing the expression of epithelial markers, particularly E-cadherin, which is the molecular hallmark of an epithelial phenotype. (6) Atypical protein kinase C-iota (aPKC-i) is regarded as a human oncogene and potential therapeutic target in various human tumors, including non-small-cell lung cancer and hepatocellular carcinoma. (7) A recent study has shown that targeting aPKC-i reduces transforming growth factor b (TGF-b)-induced EMT, including loss of the E-cadherin, cell morphology changes, and the migration of non-small-cell lung cancer cells, suggesting that aPKC-i may play an important role in TGF-b-induced EMT. (8) We previously reported that aPKC-i expression is positively correlated with human CCA differentiation and invasion, in contrast to that of E-cadherin. (9) We also showed that aPKC-i is involved in TGF-b1-induced EMT in CCA cells, while the expression of aPKC-i was associated with Snail. (10) These observations suggest that aPKC-i may reflect the differentiation and invasive potential of CCA and that aPKC-i may function to promote EMT by regulating Snail.
Cancer cell invasion and metastasis are closely related to host immunity. Recent studies indicate that EMT, a crucial step for cancer invasion and metastasis, can accelerate cancer metastasis by not only enhancing invasion but also acting on immunosuppression mechanisms in melanoma. (11) 
Foxp3
1 nTreg cells mediate immunosuppression and play an important role in cancer immune evasion. (13) In this study, we report that overexpression of aPKCi, phosphorylated-aPKC-i (P-aPKC-i), and Snail, as well as infiltrated Treg cells, is significantly associated with poor prognosis in CCA patients. We first demonstrate that aPKC-i induces CCA cell EMT and immunosuppressive nTreg-like CD4 
1 cells by regulating Snail. Furthermore, we investigated the specific molecular mechanisms by which aPKC-i regulates Snail during EMT. aPKC-i directly phosphorylated specificity protein 1 (Sp1) at Ser59 and activated Sp1-regulated Snail expression through increased binding to the Snail promoter. Sp1 is a transcription factor involved in EMT and in regulating tumor invasion and metastasis in various cancers. (14) Expression of Sp1 and Ser59-phosphorylated Sp1 (P-Sp1) as well as their correlation with the clinicopathological features of CCA were also assessed. Moreover, we studied the effects on EMT and host immunity by interfering with the aPKC-i/P-Sp1/ Snail signaling pathway. Taken together, these data strongly suggest that aPKC-i promotes EMT and induces immunosuppression in human CCA cells through an aPKC-i/P-Sp1/Snail signaling pathway.
ARTICLE INFORMATION:

Materials and Methods
PATIENTS AND SPECIMENS
Paired human extrahepatic CCA tissues and nontumor tissues (2 cm distant from tumor, n 5 64) were obtained during surgical resection at the Affiliated Tongji Hospital, Huazhong University of Science and Technology, China, between January 2012 and March 2016. Ethical approval for this study was obtained from the Tongji Hospital Research Ethics Committee. None of the patients had received any adjuvant therapy before surgery. All diagnoses were confirmed by two independent pathologists. The clinicopathological characteristics of the 64 extrahepatic CCA patients are shown in Supporting Table S1 .
IMMUNOHISTOCHEMISTRY
Immunostaining (streptavidin-biotin complex method) and semiquantitative analysis were performed to determine the expression of aPKC-i, P-aPKC-i, Snail, CD4, CD8, CD25, Foxp3, Sp1, and P-Sp1 as reported. (10) Immunohistochemical (IHC) results were semiquantitatively classified into five groups according to the percentage of positively stained cells: 0, negative; 1, <25% positive cells in specimen; 2, 25%-50% positive cells in specimen; 3, 50%-75% positive cells in specimen; 4, >75% positive cells in specimen. The signal intensity was evaluated as follows: 0, negative; 1, pale yellow staining; 2, buffy staining; 3, strong staining. The total score was assessed by combining the two parameters. In this study, total score 4 was regarded as low expression and >4 as high expression in specimens. The semiquantitative analysis was conducted for the stained sections by three independent investigators who were blinded to the patient conditions.
CELL LINES
Human CCA cell lines TFK-1 and HuCCT-1 (kindly provided by Prof. Peter Schemmer, University Hospital Graz, Graz, Austria) were used. Cell lines were cultured in Roswell Park Memorial Institute 1640 medium (Gibco, CA) containing 10% fetal bovine serum and 1% penicillin-streptomycin solution (Beijing Solarbio Science & Technology Co., Beijing, China) at 378C in a 5% CO 2 atmosphere.
WESTERN BLOTTING
Western blotting (WB) analysis was employed to detect the expression of aPKC-i, P-aPKC-i, Snail, CD4, CD8, CD25, Foxp3, Sp1, P-Sp1, and related EMT markers as described. (15) The antibodies used in this study are listed in Supporting Table S2 . To quantify the relative expression levels of the proteins, the intensity of the specific bands was estimated using the Image J2X analysis software package (National Institute of Mental Health, Bethesda, MD).
QUANTITATIVE REAL-TIME PCR
Total RNA was extracted from clinical specimens or cell lines using TRIzol reagent (Life Technologies, CA) and used to synthesize complementary DNA (cDNA) with a reverse transcriptase kit (Takara Bio Inc., Dalian, China) according to the manufacturer's instructions. Quantitative real-time PCR was performed using a SYBR Premix EX Taq kit (Takara Bio Inc.) according to the standard protocol. Relative expression levels of mRNAs were normalized as reported. (9) IHC was used to examine the levels of aPKC-i, Snail, and immune cell markers such as CD4, CD8, CD25, and Foxp3 in 64 paired CCA and adjacent nontumor samples ( Fig. 1A; Supporting Fig. S1A ). The results were confirmed by WB and quantitative real-time PCR (Supporting Fig. S1B,C) . In IHC experiments, we found that aPKC-i was localized to the cytoplasm of cancer cells, while Snail was mostly positioned in the nucleus. aPKC-i and Snail expression were significantly higher in CCA samples than in pair-matched nontumor tissues. Overexpression of P-aPKC-i, which is the activated form, was observed in CCA tissues; and, as expected, patients with high P-aPKC-i expression exhibited a shorter overall survival (OS) compared to those with low expression (Supporting Fig. S2A-C) . Levels of CD4, CD25, and Foxp3 were also higher in CCA tissues compared with pair-matched nontumor tissues. Conversely, CD8 expression was significantly lower. Flow cytometry was further employed to confirm the infiltration of CD4 1 , CD25
IN VITRO IMMUNE CELLS COCULTURED WITH TUMOR CELLS
1
, and Foxp3
1 cells in CCA specimens (Fig. 1B) . We next investigated whether the expression of aPKC-i, P-aPKC-i, Snail, and immune cell markers was associated with clinicopathological characteristics and prognosis. Overexpression of aPKC-i, P-aPKC-i, and Snail was related to lymph node metastasis (v 2 5 7.662, 10.322, and 6.284; P 5 0.006, P 5 0.001, and P 5 0.012, respectively), tumor-node-metastasis (TNM) stage III-IV (v 2 5 19.307, 16.364, and 10.848; P < 0.001, P < 0.001, and P 5 0.001), and medium/poor differentiation (v 2 5 16.366, 25.790, and 13.110; P < 0.001, P < 0.001, and P < 0.001) in CCA ( Table 2) .
We further investigated whether there was an association between aPKC-i and Snail in CCA specimens: 73.81% (31 cases) of samples with high aPKCi (42 cases) showed high Snail, whereas 59.01% (13 cases) of samples with low aPKC-i (22 cases) exhibited low Snail, indicating that aPKC-i is closely correlated with the high Snail expression (c 5 0.323, P 5 0.009). Semiquantitative analysis of the above IHC results also indicated that high aPKC-i expression was closely associated with positive CD4, CD25, and Foxp3 immunoreactivity (c 5 0.654, 0.515, and 0.584; P < 0.001, P < 0.001, and P < 0.001, respectively), while low aPKC-i was related to high CD8 expression (c 5 -0.391, P 5 0.001). Double immunofluorescence staining of tumor tissues showed that aPKC-i in tumor cells was significantly positively associated with CD4, CD25, and Foxp3 in stromal (Fig. 1C) .
Moreover, a Kaplan-Meier analysis showed that patients with high aPKC-i, Snail, CD4, CD25, and/ or Foxp3 displayed a shorter OS compared to those with low expression, while those with low CD8 expression showed a shorter OS (Fig. 1D ). OS was also statistically associated with coexpression of aPKCi and Snail or immune cell markers (Supporting Fig.  S2D ). Multivariate Cox regression analyses indicated that aPKC-i, P-aPKC-i, Snail, and immune cell markers were independent prognostic factors for OS in CCA patients (Supporting Table S3 ). These results indicate that aPKC-i may function to promote EMT and interact with immune cells by regulating Snail in CCA. 
ESTABLISHMENT OF HUMAN CCA CELL LINES WITH EMT-LIKE CHANGES BY aPKC-i TRANSFECTION
Previously, we showed that aPKC-i may play an important role in regulating EMT in human CCA cell lines. (10, 11) In the present study, we first established two stable human CCA cell lines, TFK-1 and HuCCT-1, with up-regulated aPKC-i expression levels in vitro by transfection with human aPKC-i cDNA. Along with aPKC-i up-regulation, both TFK-1 and HuCCT-1 cells showed EMT-like mRNA and protein expression profiles ( Fig To further examine the effects of aPKC-i in CCA invasion and metastasis, CCA cells that stably upregulate aPKC-i were implanted subcutaneously and intravenously into Balb/C nude mice. More tumor cells metastasized to the lungs of nude mice in the treatment group (Fig. 2E) . Meanwhile, the volumes of xenograft tumors arising from aPKC-i cDNA-transfected CCA cells were larger and more aggressive than those in the blank and negative control groups (Fig.  2F) . aPKC-i mRNA and protein expression levels were significantly increased in the treatment groups (Fig. 2F) . These results further suggest that increased aPKC-i can facilitate tumor growth and metastasis in CCA in vivo.
INDUCTION OF
IMMUNOSUPPRESSIVE CD4 1 Foxp3 1 CELLS BY aPKC-i
-TRANSDUCED HUMAN CCA CELLS WITH EMT-LIKE CHANGES
To evaluate the interaction between immune cells and human CCA cells with EMT-like changes, fresh human PBMCs were first cultured with aPKC-i 1 CCA cells. After 5 days, the proliferation of PBMCs was decreased (Fig. 3A) , and the numbers of CD4 1 
and CD8
1 cells were decreased compared to PBMCs cultured with the negative control and blank groups (Fig. 3B) . Furthermore, the number of CD4 1 cells was detected in the culture. We found that Foxp3, which is a specific transcription factor for immunosuppressive activity of nTreg cells, (16) was markedly increased in CD4 1 cells compared to PBMCs cultured with aPKC-i -CCA cells (Fig. 3C) Fig. S5 ). We next transfected specific aPKC-i small interfering RNA (siRNA) into aPKC-i 1 CCA cells. Along with decreased aPKC-i levels, the EMT-like changes in these cells were reversed, including the downregulation of N-cadherin, up-regulation of E-cadherin and b-catenin, and reduced cell proliferation, invasion, and migration, as well as reduced numbers of Treglike cells in coculture (Supporting Fig. S6) . The above results show that aPKC-i plays an essential role in inducing immunosuppressive Treg-like cells by regulating EMT in CCA cells.
We further evaluated the suppressive activity of CD4 1 cells cocultured with aPKC-i 1/-CCA cells. CD4
1 cells cocultured with aPKC-i 1 CCA cells showed markedly decreased T-cell proliferation, in contrast to CD4
1 cells cocultured with aPKC-i -CCA cells (Fig. 3D) . Many studies have shown that interleukin 2 (IL-2) and TGF-b1 are Treg cell inducers. IL-2, in cooperation with the cytokine TGF-b1, is required for Treg cell differentiation. (18) We found that IL-2 and TGF-b1 expression levels were significantly higher in aPKC-i 1 CCA cell supernatants than in aPKC-i -CCA cell supernatants (Fig. 3E) . 
SNAIL IS CRUCIAL FOR aPKC-i-INDUCED, EMT-LIKE CHANGES AND IMMUNOSUPPRESSION IN HUMAN CCA CELLS
Our previous studies suggested that aPKC-i may induce EMT by regulating Snail.
(11) Therefore, we first investigated whether Snail was regulated by aPKC-i. Snail protein and mRNA levels were upregulated in aPKC-i-overexpressing TFK-1 cells or down-regulated in aPKC-i-deficient HuCCT-1 cells ( Figs. 2A and 4A ; Supporting Figs. S3 and S6A). To further study the roles of Snail in aPKC-i-induced, EMT-like changes, Snail was knocked down by transfecting aPKC-i 1 CCA cells with Snail siRNA. Following the knockdown of Snail, EMT-like changes were almost reversed compared with negative control groups, including the expression levels of EMT markers ( Fig. 4A; Supporting Fig. S8 ) and cell proliferation, invasion, and migration (Fig. 4B) . Along with the down-regulation of Snail expression, Snail siRNA transfection significantly decreased the ability of aPKC-i 1 tumor cells to induce immunosuppressive CD4 1 Foxp3 1 nTreg-like cells compared with the negative control groups (Fig. 4C) , promoted PBMC and T-cell proliferation, and decreased the immunosuppressive activity of CD4 1 cells and Treg-inducible cytokines (Supporting Fig. S9) . Similarly, when Snail was up-regulated by transfecting CCA cells with aPKC siRNA with Snail cDNA, these cells showed EMT-like features compared with negative control groups, such as decreased epithelial markers and increased mesenchymal markers, accompanied by increased cell proliferation, invasion, and migration (Supporting Fig. S10 ). These findings indicated that Snail is crucial for aPKC-i-induced, EMT-like changes and immunosuppression in human CCA cells.
To further evaluate the role of Snail in aPKC-i 1 CCA cells, a xenograft tumor model and a pulmonary metastasis tumor model were established in nude mice. Fewer metastatic nodules were found in the lungs of Snail siRNA treatment groups (Fig. 4D) . Moreover, the volumes of tumors from aPKC-i 1 CCA cells transfected with Snail-specific siRNA were smaller compared with blank and negative control groups (Fig.  4E) . These tumors were less aggressive than tumors from the blank and negative control groups, and Snail mRNA and protein levels detected by IHC, WB, and quantitative real-time PCR were lower in the treatment groups than in the untreated groups (Supporting Fig. S11 ). In conclusion, the assay confirmed that Snail plays an important role in aPKC-i-mediated human CCA progression and metastasis in vivo.
IDENTIFICATION OF Sp1 DIRECTLY PHOSPHORYLATED BY aPKC-i AT Ser59 AND ITS CORRELATION WITH POOR PROGNOSIS IN CCA PATIENTS
To examine the molecular mechanism by which aPKC-i regulates Snail expression in EMT, we first performed coimmunoprecipitation (co-IP) experiments to determine whether aPKC-i directly interacts with Snail. Expression of aPKC-i and Snail was not detected in the precipitated protein complex, suggesting that aPKC-i indirectly regulated Snail through other molecules (Supporting Fig. S12) 1 cells isolated from the coculture system were tested for immunosuppressive activity on T-cell proliferation in response to anti-CD3 antibody by CCK-8 assay. (E) Enzyme-linked immunosorbent assay was used to detect the expression of Treginducible cytokines such as IL-2 and TGF-b1 in various CCA cell supernatants as indicated. *P < 0.05, **P < 0.001. Data are shown as mean 6 standard deviation of at least three independent experiments. Abbreviations: NC, negative control; OD, optical density. phosphorylated peptides, were identified according to the special statistical standards (fold change 1.2, P 0.05). Among these 311 phosphorylated peptides, 169 were up-regulated and 142 were down-regulated after aPKC-i cDNA transfection, as shown by hierarchical clustering (Fig. 5A) . Gene ontology and Kyoto Encyclopedia of Genes and Genomes software were used to identify phosphorylated proteins and peptides involved in pathways which regulate EMT. The results showed that the TGF-b signaling pathway was conducted, which is the most crucial regulating pathway in EMT. We found that a specific peptide sequence of Sp1 was involved in the TGF-b signaling pathway in EMT, which was markedly up-regulated (fold change 5 1.424924, P < 0.05) after aPKC-i cDNA transfection. In addition, research has demonstrated that Sp1 correlates with cancer cell migration and metastasis through regulation of EMT in various cancers. (19) Nevertheless, the mechanism of Sp1 in the regulation of EMT needs to be further elucidated. The phosphorylation sites in the specific peptide of Sp1 were Ser59, Thr10, Ser17, and Ser20, which corresponded to the Ser48, Thr49, Ser56, and Ser59 sites in full-length Sp1. Many studies on Sp1 phosphorylation have reported that Ser59 is a more significant phosphorylation site than the other three. (20) To confirm the role of aPKC-i in Sp1 phosphorylation at Ser59 (P-Sp1), WB was used to detect Sp1 and P-Sp1 in aPKC-i 1 CCA cells compared with blank and negative controls (Fig. 5B) . Double immunofluorescence staining of tumor tissues also showed that aPKC-i and P-Sp1 were expressed in cancer cells (Supporting Fig. S13A ). The results confirmed that Sp1 and P-Sp1 were up-regulated along with the overexpression of aPKC-i.
To investigate whether Sp1 might be a direct substrate of aPKC-i, we performed co-IP experiments. aPKC-i physically interacted with Sp1, indicating that aPKC-i directly phosphorylated Sp1 at Ser59 (Fig.  5C) . Moreover, IHC, WB, and quantitative real-time PCR were employed to analyze Sp1 and P-Sp1 expression in human CCA tissues (Fig. 5D ). Sp1 and P-Sp1 expression was significantly higher in tumor tissues than in paired adjacent nontumor tissues (P < 0.005). IHC experiments revealed that Sp1 was localized to the cytoplasm or nucleus of CCA cells, whereas P-Sp1 was mostly located in the nucleus (Fig. 5D) . We next examined the relationship between Sp1 or P-Sp1 expression and the clinicopathological characteristics and prognosis of CCA patients. Overexpression of Sp1 and P-Sp1 was related to lymph node metastasis (v 2 5 10.787 and 7.522; P 5 0.001 and P 5 0.006), TNM stage (v 2 5 25.010 and 20.237; P < 0.001 and P < 0.001), and medium/poor differentiation (v 2 5 4.550 and 10.347; P 5 0.033 and P 5 0.001) in CCA (Supporting Table S4 ). A Kaplan-Meier analysis indicated that CCA patients with high Sp1 and P-Sp1 expression exhibited a shorter OS than those with low expression (P < 0.001) (Fig. 5E ).
aPKC-i-INDUCED PHOSPHORYLATION OF Sp1 AT Ser59 REGULATES SNAIL EXPRESSION THROUGH IMPROVED Sp1 BINDING TO THE SNAIL PROMOTER
Sp1, a very well-known transcription factor, regulates the expression of target genes by binding to GCrich motifs in promoter regions with high affinity. (21) Double immunofluorescence staining of tumor tissues showed that P-Sp1 and Snail were expressed in cancer cells (Supporting Fig. S13B ). Combined with the above IHC results, there is a significant positive correlation between P-Sp1 levels and Snail expression (c 5 0.397, P 5 0.001). To investigate whether Sp1 binds the promoter regions of Snail and whether aPKC-iinduced Sp1 Ser59 phosphorylation influences Sp1 binding to the Snail promoter, we first performed co-IP experiments. Sp1 and Snail were detected in the corresponding precipitated protein complexes, indicating that Sp1 interacted directly with Snail (Fig. 6A) . Then, we constructed wild-type (WT) Sp1, Ser59 nonphosphorylatable mutant SP1 (S59A-Sp1), and Ser59 phosphomimetic mutant Sp1 (S59D-Sp1) eukaryotic expression vectors and generated CCA cells that stably expressed these constructs. The level of PSp1 was higher in S59D-Sp1 cells and lower in S59A-Sp1 cells than in WT Sp1 cells. Chromatin immunoprecipitation was performed in WT Sp1, S59A-Sp1, and S59D-Sp1 cells; and the results showed that Sp1 directly bound to the promoter regions of Snail and that the enrichment of the immunoprecipitated Snail promoter region was increased in S59D-Sp1 cells and decreased in S59A-Sp1 cells compared with WT Sp1 cells (Fig. 6B ). WB and quantitative real-time PCR were performed to further confirm that Snail protein and mRNA levels were consistent with the level of PSp1 ( Fig. 6C; Supporting Fig. S14 ). These results demonstrated that aPKC-i-induced Sp1 Ser59 phosphorylation increased Snail expression by enhancing Sp1 binding to the Snail promoter.
THE ROLE OF Sp1 Ser59 PHOSPHORYLATION IN aPKC-i/ SNAIL-INDUCED, EMT-LIKE CHANGES AND IMMUNOSUPPRESSION IN HUMAN CCA CELLS
To investigate the potential function of Sp1 Ser59 phosphorylation in aPKC-i/Snail-induced, EMT-like changes and immunosuppression, we generated CCA cells expressing Sp1 mutants with various Ser59 phosphorylation states as above. WB and quantitative realtime PCR demonstrated that S59D-Sp1 cells have higher levels of N-cadherin and lower levels of Ecadherin and b-catenin, whereas S59A-Sp1 cells displayed the opposite expression patterns compared with WT Sp1 cells ( Fig. 6C; Supporting Fig. S14 ). These results confirmed that Sp1 Ser59 phosphorylation promotes aPKC-i/Snail-induced EMT in CCA cells. Furthermore, S59D-Sp1 cells exerted potent effects on promoting the migration and invasiveness of CCA cells, whereas S59A-Sp1 cells showed the opposite effects, compared with WT Sp1 cells (Fig. 6D) . Similar results were also observed in Cell Counting Kit-8 (CCK-8) assays to detect cell proliferation (Fig. 6D) .
Combined with the above conclusion that aPKC-i/ Snail-induced EMT induces immunosuppression in CCA, we conducted further experiments to investigate the relationship between Sp1 Ser59 phosphorylation and immunosuppression in CCA cells. S59D-Sp1 cells exhibited a higher ability to induce immunosuppressive CD4
1
Foxp3
1 nTreg-like cells, whereas lower immunosuppression ability was observed in S59A-Sp1 cells compared with WT Sp1 cells (Fig. 6E) .
Our study showed that aPKC-i interacted directly with and phosphorylated Sp1 at Ser59, and aPKC-iinduced Sp1 Ser59 phosphorylation was confirmed to regulate Snail expression by improving Sp1 binding to the Snail promoter. We also studied the effects on EMT and host immunity by interfering with the aPKC-i/P-Sp1/Snail signaling pathway. In summary, these data strongly suggest that aPKC-i promotes EMT and induces immunosuppression in human CCA cells through an aPKC-i/P-Sp1/Snail signaling pathway (Fig. 6F ).
Discussion
EMT is thought to be a pivotal step in cancer cell invasion and metastasis, as well as in cancer cell evasion from immune surveillance. (3, 4) Our previous studies showed that aPKC-i, a polarization regulatory protein, has a critical role in the regulation of EMT in CCA. (10, 11) However, the function and molecular mechanisms of aPKC-i in EMT regulation and its Many studies have demonstrated that Snail reduces the expression of E-cadherin and is closely associated with cancer invasion and metastasis by EMT. (6, 22) The regulation of Snail by PKC/glycogen synthase kinase 3b signaling was reported to be crucial for epidermal growth factor-induced EMT of cancer cells. (23) In this study, we found that aPKC-i, P-aPKC-i, and Snail were co-overexpressed in CCA specimens; and there was a positive correlation between them. We hypothesized that aPKC-i plays an important role in inducing EMT by regulating Snail.
To further confirm our hypothesis, CCA cells were transfected with aPKC-i cDNA. Along with aPKC-i increases, CCA cells showed EMT-like changes in cellular characteristics and the expression of EMT markers compared with mock transfectants. Our results are consistent with reports claiming that aPKCi promotes cancer invasion and metastasis. (24) We also found that Snail expression was regulated by aPKC-i. CCA cells transfected with aPKC-i cDNA or aPKC-i siRNA showed enhanced or reduced Snail expression, respectively. Furthermore, knocking down Snail in aPKC-i 1 CCA cells almost completely reversed aPKC-i-induced, EMT-like changes. Subsequently, up-regulating Snail in CCA cells transfected with aPKC-i siRNA prevented EMT alterations from occurring after aPKC-i silencing in CCA cells. Our results showed that Snail is crucial for aPKC-iinduced, EMT-like changes in CCA cells.
To elucidate the molecular mechanism by which aPKC-i regulates Snail to induce EMT, we performed co-IP experiments and demonstrated that aPKC-i indirectly regulated Snail through other molecules. aPKC-i, a serine/threonine kinase, controls a large number of cellular functions through specific phosphorylation of intracellular substrates. It is an atypical PKC with the general consensus phosphorylation site of Ser/Thr-X-Arg/Lys (where X represents any amino acid). (25) We first globally identified potential substrates of aPKC-i-dependent phosphorylation by quantitative phosphoproteomic analysis based on iTRAQ and determined that aPKC-i phosphorylated Sp1 at Ser59 site (P-Sp1) in vitro. Accumulating evidence indicates that Sp1 is overexpressed in various cancers and is correlated with cancer cell migration and metastasis through the regulation of EMT. (26) In the study, we found that aPKC-i interacts directly with Sp1 through co-IP assays, meaning that Sp1 might be a direct substrate for aPKC-i phosphorylation. Generally, these results indicated that Sp1 was directly phosphorylated at Ser59 in response to aPKC-i activation.
Previous studies have revealed that posttranslational modifications are involved in regulating the DNAbinding affinity, transactivational activity, and protein stability of Sp1. (27) Here, we focused mainly on phosphorylation and identified a protein kinase that phosphorylates Sp1, which further regulates the expression of Sp1 target genes by increasing Sp1 binding to promoter regions. Recently, various reports have suggested that Sp1 can induce TGF-b-mediated, EMT-activating Snail expression and can cooperate with activated Smad complexes to express EMT-associated marker genes, (13, 28) playing an important role in regulating tumor invasion and metastasis. However, the function of Sp1 phosphorylation and its relationship with aPKC-i/Snail in EMT of CCA is unknown. The current study showed that aPKC-i-induced Sp1 Ser59 phosphorylation caused an increase in Snail expression by enhancing Sp1 binding to the Snail promoter. Co-IP assays also demonstrated that Sp1 directly interacted with aPKC-i and Snail, whereas aPKC-i did not interact with Snail. In view of IHC experiment showing that Sp1 localized to the cytoplasm or nucleus whereas phosphorylated Sp1 was mostly found in the nucleus, we postulate that aPKC-i interacts with and phosphorylates Sp1 at Ser59 site in cytoplasm, resulting in the translocation of phosphorylation Sp1 into the nucleus to bind the Snail promoter. Furthermore, we found that CCA cells with high expression of PSp1 (S59D-Sp1) displayed enhanced cancer cell invasion and motility, along with increased mesenchymal marker expression and decreased epithelial marker expression compared with low-P-Sp1 expression cells (S59A-Sp1). These results indicated that Sp1 Ser59 phosphorylation promoted aPKC-i/Snail-induced, EMT-like changes in CCA cells.
The host immune system is widely regarded as playing a pivotal role in cancer progression. (29) Notably, recent studies showed that EMT can accelerate cancer metastasis not only by enhancing invasion but also by acting on host immunity. (13, 30) In the present study, we first demonstrated that high expression of CD8 and low expression of CD4, CD25, and Foxp3 in CCA tissue were positively correlated with better outcomes. Our results were consistent with studies claiming that immune cell markers can serve as prognostic and predictive markers for CCA. (31) Meanwhile, we found a significant positive relationship between the expression of aPKC-i and CD4, CD25, and Foxp3 and a negative correlation between aPKC-i and CD8. Based on our results, we hypothesized that aPKC-i may play an important role in recruiting immune cells by inducing EMT in CCA. However, the interactions and specific mechanism between CCA cells and immune cells during EMT (32) However, the results of these trials were disappointing, owing to host immunosuppression. Abolishing host immunosuppression will help to improve antitumor immune responses in cancer patients. In summary, we found that aPKC-i, Snail, and infiltration immunosuppressive cells are significantly associated with poor prognosis in CCA patients. Snail played a critical role in aPKC-i-induced EMT and immunosuppression in CCA cells. We demonstrated that aPKC-i directly interacted with and phosphorylated Sp1, and aPKC-i-induced Sp1 Ser59 phosphorylation was confirmed to regulate Snail expression by increasing Sp1 binding to the Snail promoter. Our results strongly suggest that aPKC-i promotes EMT and induces immunosuppression in human CCA cells through an aPKC-i/P-Sp1/Snail pathway. Inhibition of this pathway may abolish cancer metastasis and immunosuppression. This strategy will provide an effective approach to improve the effect of anticancer therapy in CCA.
